Fever Signs and Symptoms Fever
Conditions
Interventions
Please note that, as of 14 January 2008, the anticipated start and end dates of this trial have been updated from 1 July 2004 and 31 December 2006 to 1 December 2004 and 30 November 2007, respectively
Sponsors
Department of Health (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Previously well children aged >6 months and <5 years presenting to primary care with a temperature at least 38°C.
Exclusion criteria
Exclusion criteria: Excluding children with epilepsy or known contraindications to the study medicines.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Fever clearance in the first four hours (data logger) 2. 48-hour discomfort score (parent symptom score) | — |
Secondary
| Measure | Time frame |
|---|---|
| We will examine the time under fever threshold first 24 hours, adverse events and departures from protocol, the pattern of discomfort scores between 4 and 48 hours, the number of night-time doses administered, other symptoms and the NHS costs associated with the discomfort scores at 48 hours and 5 days. | — |
Countries
United Kingdom
Outcome results
None listed